Cardiology at Changhai Hospital Shanghai | CMCS

Expert Heart Disease Care at One of Shanghai's Premier Military Medical Centers

The Department of Cardiology at Changhai Hospital — affiliated with Naval Medical University (Second Military Medical University) — is one of Shanghai's most distinguished cardiology centers, with a national reputation for excellence in interventional cardiology, structural heart disease, cardiac electrophysiology, heart failure, and the management of complex cardiovascular conditions. With a strong military medical heritage and a high-volume interventional program, Changhai Hospital's cardiology department combines outstanding clinical expertise with a world-class research program, offering international patients access to some of China's most eminent cardiologists and the latest evidence-based treatments and interventional techniques.

For international patients with coronary artery disease, heart failure, structural heart disease, arrhythmias, or a complex cardiovascular condition — Changhai Hospital's cardiology department offers an unparalleled combination of clinical expertise, interventional capability, and research leadership. China Medical Concierge Shanghai (CMCS) provides seamless end-to-end coordination for international patients throughout their cardiac care journey at Changhai Hospital.

About the Department

Changhai Hospital's cardiology department is a national key clinical specialty operating dedicated cardiac care wards, a coronary care unit (CCU), multiple cardiac catheterization laboratories, an electrophysiology laboratory, an echocardiography laboratory, a cardiac imaging center, a heart failure clinic, a structural heart disease program, and works in close collaboration with cardiac surgery, vascular surgery, and critical care through a fully integrated multidisciplinary Heart Team.

Faculty members publish regularly in leading cardiology journals including Journal of the American College of Cardiology, Circulation, European Heart Journal, JACC: Cardiovascular Interventions, and Heart Rhythm.

Conditions Treated

Coronary Artery Disease (CAD)

• Stable Coronary Artery Disease — Optimal medical therapy; FFR and iFR-guided revascularization; PCI with drug-eluting stents; CABG coordination for complex multivessel disease; CCTA for non-invasive assessment
• Acute Coronary Syndromes (ACS) — Primary PCI for STEMI (24/7 primary PCI capability); radial access PCI; drug-eluting stent implantation; DAPT optimization (prasugrel, ticagrelor); cangrelor for bridging; mechanical circulatory support for cardiogenic shock
• Complex PCI — Left main PCI; bifurcation PCI; chronic total occlusion (CTO) PCI; calcified lesion PCI with rotational atherectomy and intravascular lithotripsy (IVL); intravascular imaging-guided PCI (IVUS, OCT)
• Post-ACS Management — Cardiac rehabilitation; PCSK9 inhibitors (evolocumab, alirocumab); inclisiran; icosapentaenoic acid (Vascepa)

Heart Failure

• HFrEF — Quadruple therapy: ARNI (sacubitril/valsartan) + beta-blocker + MRA + SGLT2 inhibitor (dapagliflozin/empagliflozin); ivabradine; hydralazine + nitrates
• HFpEF — SGLT2 inhibitors (empagliflozin, dapagliflozin); spironolactone; blood pressure control; finerenone
• Advanced Heart Failure — Inotropic support; Impella; VA-ECMO; CRT; ICD; LVAD evaluation; cardiac transplantation evaluation
• Cardiogenic Shock — Impella CP and 5.5; VA-ECMO; multidisciplinary shock team; early revascularization
• Cardiac Amyloidosis — Tafamidis for ATTR-CM; acoramidis; eplontersen and patisiran for hereditary ATTR; PYP scan for ATTR diagnosis; daratumumab for AL amyloidosis
• Hypertrophic Cardiomyopathy (HCM) — Beta-blockers; mavacamten (cardiac myosin inhibitor); aficamten; alcohol septal ablation; surgical myectomy coordination; ICD for SCD prevention
• Dilated Cardiomyopathy — Guideline-directed medical therapy; genetic testing (TTN, LMNA, SCN5A); ICD for LMNA-DCM

Structural Heart Disease

• TAVR (Transcatheter Aortic Valve Replacement) — For severe aortic stenosis in high, intermediate, and low surgical risk; transfemoral approach; valve-in-valve TAVR; one of Shanghai's experienced TAVR programs
• MitraClip / TEER (Transcatheter Edge-to-Edge Repair) — For primary and secondary mitral regurgitation; COAPT criteria for functional MR
• Left Atrial Appendage Closure (LAAC) — Watchman FLX and Amulet for AF patients with contraindication to anticoagulation
• Patent Foramen Ovale (PFO) Closure — For cryptogenic stroke; Amplatzer PFO Occluder
• ASD & VSD Closure — Transcatheter closure of atrial and ventricular septal defects; Amplatzer devices
• Pulmonary Valve Interventions — Transcatheter pulmonary valve replacement for conduit dysfunction

Cardiac Electrophysiology

• Atrial Fibrillation (AF) — Rate and rhythm control; pulmonary vein isolation (PVI) by radiofrequency and cryoablation; pulsed field ablation (PFA) for AF; left atrial appendage closure; cardioversion; antiarrhythmic drugs
• Atrial Flutter — Cavotricuspid isthmus (CTI) ablation; cardioversion
• SVT — AVNRT and AVRT ablation; WPW syndrome ablation
• Ventricular Tachycardia (VT) — Catheter ablation for scar-related and idiopathic VT; epicardial ablation; ICD programming optimization
• Bradyarrhythmias — Permanent pacemaker implantation; His bundle pacing and left bundle branch area pacing (LBBAP); leadless pacemaker (Micra); CRT-P and CRT-D
• Inherited Arrhythmia Syndromes — Long QT syndrome; Brugada syndrome; CPVT; genetic testing and family screening
• ICD & S-ICD — Transvenous ICD; subcutaneous ICD (S-ICD); wearable cardioverter-defibrillator (WCD)

Valvular Heart Disease

• Aortic Stenosis — TAVR; surgical AVR coordination; balloon aortic valvuloplasty as bridge
• Mitral Regurgitation — MitraClip TEER; surgical repair coordination
• Mitral Stenosis — Percutaneous mitral balloon valvuloplasty (PMBV) for rheumatic MS
• Tricuspid Regurgitation — Transcatheter tricuspid interventions; TriClip

Pulmonary Hypertension

• PAH — ERA (bosentan, macitentan, ambrisentan) + PDE5i (sildenafil, tadalafil) + prostacyclin (selexipag, iloprost, IV epoprostenol); sotatercept for PAH; riociguat for CTEPH
• CTEPH — Riociguat; balloon pulmonary angioplasty (BPA); pulmonary endarterectomy coordination

Aortic Disease

• Aortic Aneurysm — TEVAR for descending thoracic aortic aneurysm; EVAR for abdominal aortic aneurysm; open surgical repair coordination
• Aortic Dissection — Type A: emergency surgical repair coordination; Type B: medical management; TEVAR for complicated Type B

Cardiac Imaging

• Echocardiography — TTE and TEE; 3D echocardiography; stress echocardiography; intracardiac echocardiography (ICE) for procedural guidance
• Cardiac CT — Coronary CT angiography (CCTA); TAVR planning CT; structural heart disease planning
• Cardiac MRI — Myocardial viability; cardiomyopathy characterization; cardiac amyloidosis; myocarditis
• Nuclear Cardiology — Myocardial perfusion imaging; PYP scan for ATTR amyloidosis; FDG-PET for cardiac sarcoidosis

Why International Patients Choose Changhai Cardiology

• 24/7 Primary PCI — Round-the-clock primary PCI capability for STEMI; military-grade emergency response
• CTO PCI Expertise — Complex chronic total occlusion PCI with intravascular imaging guidance
• Pulsed Field Ablation (PFA) — Latest-generation AF ablation technology
• Cardiac Amyloidosis Program — Tafamidis, acoramidis, and eplontersen for ATTR-CM; PYP scan diagnosis
• Mavacamten for HCM — Cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy
• Sotatercept for PAH — Novel activin receptor ligand trap for pulmonary arterial hypertension
• Cost-Effectiveness — World-class cardiac care at significantly lower cost than equivalent treatment in Western countries

The CMCS Patient Journey

1. Initial Inquiry — Share your cardiac diagnosis, ECG, echocardiography reports, cardiac catheterization data, and current medications with CMCS.
2. Medical Record Preparation — We translate and organize your records for specialist pre-consultation review.
3. Specialist Matching — We identify the most appropriate cardiologist based on your condition — interventional cardiology, structural heart disease, heart failure, electrophysiology, or pulmonary hypertension.
4. MDT Submission — Where appropriate, we facilitate pre-arrival case review by Changhai's cardiac Heart Team.
5. Priority Scheduling — We secure a consultation with minimal waiting time.
6. Travel & Logistics — Assistance with visa invitation letters, accommodation near Changhai Hospital, and Shanghai airport transfers.
7. Procedural Coordination — Full coordination of cardiac catheterization, TAVR, ablation, device implantation, or other cardiac procedures.
8. Post-Procedure Follow-Up — Procedure report translation, medication guidance, and remote follow-up coordination after you return home.

Book a Consultation

If you have coronary artery disease, heart failure, structural heart disease, an arrhythmia, or a complex cardiovascular condition — CMCS can arrange a specialist consultation with Changhai Hospital's cardiology team in Shanghai.

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com